All
USPSTF Recommends to Lower Age for Colorectal Cancer Screening, Emphasizing Early Detection
October 29th 2020As colorectal cancer is becoming more prevalent in younger patients, the U.S. Preventive Services Task Force (USPSTF) introduced a draft recommendation that, if accepted, will lower the screening age from 50 years to 45 years in those with average risk.
Tazverik a Safe and Effective Option for Heavily Pretreated Patients with Follicular Lymphoma
October 27th 2020In addition to showing clinically meaningful, durable responses, Tazverik (tazemetostat) was generally well-tolerated in heavily pretreated patients with relapsed or refractory follicular lymphoma, according to the results of an open-label, single-arm, multicenter phase 2 study.
Patients with Cancer Stand to Lose if Supreme Court Repeals ‘Obamacare’
October 27th 2020Justice Amy Coney Barrett was sworn in to the Supreme Court on Tuesday. Her vote would be instrumental in deciding the fate of the Affordable Care Act. If it’s repealed during November’s landmark case, many could lose access to cancer screening and treatment.
Adding Darzalex to Standard Treatment for High-Risk Multiple Myeloma May Delay Disease Progression
October 27th 2020A meta-analysis of six clinical trials showed that standard treatment regimens for high-risk multiple myeloma may be more effective at delaying disease progression if they are given in combination with the targeted drug Darzalex (daratumumab).